×
Back to Agenda
Nanotechnology: Application to Medical Products
Session Chair(s)
Suzanne Sensabaugh, MBA, MS
President and Principal Consultant , HartmannWillner LLC, United States
This session will address the topic of nanotechnology with a focus on its use for drugs and biologics. It will define the term; provide a basic overview of the technology and uses; and address development, scientific, and regulatory challenges.
Learning Objective : Define nanotechnology; Explain the application of nanotechnology as it relates to drugs and biologics; Describe the current landscape of medical products in development; Enumerate development, scientific, and regulatory challenges; Identify the preclinical and clinical requirements.
Speaker(s)
Michael Drues, PHD
Founder and President, Vascular Sciences, United States
Biomedical Nanotechnology: The Smaller the Thing, the Bigger the Challenge
Celia N. Cruz, PHD
Senior Product Quality Reviewer, OPS, CDER, FDA, United States
Nanomaterials in Drug Products: A Regulatory Update
Frank J Malinoski, MD, PHD
Chief Medical Officer, Liquidia Technologies, United States
Industry Perspectives of Nanomedicines: It's a Small World After All
Have an account?